메뉴 건너뛰기
Cardiovascular Drugs and Therapy
Volumn 24, Issue 5-6, 2010, Pages 459-460
Effects of sphingosine-1-phosphate on acute contractile heart failure (ACHF)
Author keywords

[No Author keywords available]
Indexed keywords

HIGH DENSITY LIPOPROTEIN; SPHINGOSINE 1 PHOSPHATE;
EID: 79958204675     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-010-6258-4     Document Type: Letter
Times cited : (6)
References (7)
  • 1
    • 34548746306 scopus 로고    scopus 로고
    • Myocardial reperfusion injury
    • Yellon D, Hausenloy D. Myocardial reperfusion injury. N Engl J Med. 2007;357:1121-35.
    • (2007) N Engl J Med , vol.357 , pp. 1121-1135
    • Yellon, D.1    Hausenloy, D.2
  • 2
    • 67349280415 scopus 로고    scopus 로고
    • Inhibition of mitochondrial permeability transition pore opening: Translation to patients
    • Gomez L, Li B, Mewton N, Sanchez I, Piot C, Elbaz M, et al. Inhibition of mitochondrial permeability transition pore opening: translation to patients. Cardiovasc Res. 2009;83:226-33.
    • (2009) Cardiovasc Res , vol.83 , pp. 226-233
    • Gomez, L.1    Li, B.2    Mewton, N.3    Sanchez, I.4    Piot, C.5    Elbaz, M.6
  • 3
    • 18844458509 scopus 로고    scopus 로고
    • The reperfusion injury salvage kinase pathway: A common target for both ischemic preconditioning and postconditioning
    • DOI 10.1016/j.tcm.2005.03.001, PII S1050173805000253
    • Hausenloy D, Tsang A, Yellon D. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med. 2005;15:69-75. (Pubitemid 40693390)
    • (2005) Trends in Cardiovascular Medicine , vol.15 , Issue.2 , pp. 69-75
    • Hausenloy, D.J.1    Tsang, A.2    Yellon, D.M.3
  • 4
    • 67349229765 scopus 로고    scopus 로고
    • Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?
    • Lecour S. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway? J Mol Cell Cardiol. 2009;47:32-40.
    • (2009) J Mol Cell Cardiol , vol.47 , pp. 32-40
    • Lecour, S.1
  • 5
    • 0029739056 scopus 로고    scopus 로고
    • The management of chronic heart failure
    • DOI 10.1056/NEJM199608153350707
    • Cohn J. The management of chronic heart failure. N Engl J Med. 1996;335:490-8. (Pubitemid 26269950)
    • (1996) New England Journal of Medicine , vol.335 , Issue.7 , pp. 490-498
    • Cohn, J.N.1
  • 6
    • 0036285606 scopus 로고    scopus 로고
    • Energy metabolism in the normal and failing heart: Potential for therapeutic interventions
    • Stanley W, Chandler M. Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Fail Rev. 2002;7:115-30.
    • (2002) Heart Fail Rev , vol.7 , pp. 115-130
    • Stanley, W.1    Chandler, M.2
  • 7
    • 35848933939 scopus 로고    scopus 로고
    • HDL and its sphingosine-1-phosphate content in cardioprotection
    • DOI 10.1007/s10741-007-9038-x, Special Issue on Cardioprotection; Guest Editors: Dennis V. Cokkinos and Gerd Heusch
    • Keul P, Sattler K, Levkau B. HDL and its sphingosine-1-phosphate content in cardioprotection. Heart Fail Rev. 2007;12:301-6. (Pubitemid 350176703)
    • (2007) Heart Failure Reviews , vol.12 , Issue.3-4 , pp. 301-306
    • Keul, P.1    Sattler, K.2    Levkau, B.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.